Harvard Alumni: Food As Medicine: Can The Right Kinds Of Food Prevent Diseases?
- October 26, 2021
Dear Oxbridge Partners and Affliates,
Food as medicine is no longer a fringe idea. From adding micronutrients to soil to combat malnutrition. in the developing world to cutting edge research exploring the role diet may play in preventing, arresting, and even reversing some of our most feared causes of death and disability.
Join HAE Southern Californian for a look at some of the leading trends in the food as medicine field and how entrepreneurs and investors are leading the way in sustainable nutrition, proactive health and Immunity protocols.
Food as Medicine: Can the Right Kinds of Food Prevent Diseases? is part of the FoodTech & Digital Health series.
Topic: Food as Medicine: Can the Right Kinds of Food Prevent Diseases?
Date: Oct 28, 2021 Time: 8:00 PM Eastern Time (US and Canada)
Zoom: https://harvard.zoom.us/j/95353838273?pwd=aUVEWGI2S2dIenB0aU9tdmNaVTl1dz09#success
Felix Bustos III
Felix Bustos III is currently serving as Co-Founder & CEO of ZB Technologies, Inc.
About ZB Tech
We’re a Health Technology company passionate about ending cancer by providing everyone with the best healthcare ecosystem.
Our team’s mission is to: end cancer. Our company’s vision is, to connect a global Digital Health Ecosystem with the best resources available for everyone to live a disease-free life.
At ZB Tech, we’re committed to solving hard NewHealth problems to make this a much better world. We attract the best and the brightest people of all backgrounds, who sincerely care about giving back to our global community through game-changing breakthroughs in science, technology, engineering, and business.
Most importantly, an innovative entrepreneurial culture, core values, and a fun-loving attitude run deep in our company’s DNA.
HelenHealth v1.0 Release
HelenHealth is a digital health platform where everyone can access the best resources to predict & prevent cancer.
On September 2019, HelenHealth.co, was soft-launched in Santa Monica, California and Boston, Massachusetts. The venture was further developed at the Harvard Innovation Labs and accelerated through Harvard Medical School’s Healthcare Innovation & Commercialization Fall 2020 cohort. The HelenHealth community is growing, and our team is very excited to release the latest version, HelenHealth.ai, this Fall 2021!
Follow our team’s committed journey to help end cancer.
Professional Background
Previously, Felix held management and senior level positions at Defense & Intelligence, Research & Development, Fortune 500, NewSpace, and high technology startup companies: Lockheed Martin Skunk Works, BAE Systems, The Spaceship Company, Virgin Galactic, and Virgin Advanced Development Programs (Virgin Orbit).
Felix was also on active duty in the U.S. Air Force and serves in the U.S. Coast Guard Reserve, as a joint staff officer, and is currently a reserve officer at the Defense Innovation Unit in Mountain View, California, providing technical/scientific expertise within the Space and Human Systems portfolios, and is the reserve lead for Artificial Intelligence.
Brandon Hoffman
Brandon serves as a Research Lead for the Chief Innovation Office & a Venture Capital Investor at Samsung NEXT. Samsung NEXT is the software & service innovation center for Samsung Electronics.
Brandon Hoffman manages Innovation & Research at Samsung NEXT, where he drives thought leadership on behalf of the Chief Innovation Officer and delivers insights on disruptive trends relating to Industries, Consumers & Technologies, and Geographies.
As an Investor for Samsung NEXT Ventures, Brandon provides early-stage capital, expertise, and access to Samsung’s distribution and scale to help accelerate and improve a startup’s success. He also co-founded and leads the Diverse Founders Initiative, which is focused on finding, investing, and elevating early-stage startups founded by diverse entrepreneurs (Black, Latinx, and Women).
Prior to his current role, he started in Strategy at Samsung NEXT, where he identified growth opportunities through collaboration with corporate development, venture capital, partnerships, and/or product development.
Before joining Samsung NEXT, he spent a few years at Morgan Stanley in Research, covering Internet & Consumer (e-commerce, online advertising, gaming), where he notably co-founded the Amazon Disruption Symposium global events series and worked on various high-profile, multi-billion dollar IPOs.
Brandon Hoffman has spent over 10 years in finance, mostly covering Consumer, Tech, and Media sectors. However, he started out as a teller before bulletproof glass at a local branch while in college, before making his way to Wall Street.
Additional experience includes being a music entrepreneur, when he built and operated a recording studio and production company. Brandon completed a dual-degree program at The Wharton School and Harvard Kennedy School, earning a MBA in Finance and a MPA in behavioral science and social impact. Brandon graduated cum laude with a B.A. in Business Administration and Music Arts from CSU Fullerton at age 20 after transferring from Cypress Community College.
Brandon is personally committed to addressing the racial wealth gap and youth unemployment in this country through business, technology, and entrepreneurship as ways to build financial empowerment and equity. His work in the community has been done through Management Leadership for Tomorrow (MLT), Echoing Green, Toigo Foundation, and the Sheila C. Johnson Fellowship at the Center for Public Leadership at Harvard. For fun, Brandon enjoys gaming with his son, traveling, writing music, eating BBQ, and Batman comics.
Michael Klein
| 2018-present | Credit Suisse |
|
|
| 2010-present | M Klein & Company |
|
|
| 1985-2008 | Citigroup |
|
Education
| 1985 | Bachelor of Science in Economics (Finance and Accounting), The Wharton School, University of Pennsylvania |
Other functions and activities
|
|
|
|
|
|
|
|
|
|
|
